|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-5-8
|
|
pubmed:abstractText |
Transplant arteriosclerosis, the hallmark feature of chronic rejection, is still the major limiting factor for the long-term success of heart transplantation. Platelets have been implicated to play a role in the pathogenesis of this disease. Therefore the aim of this study was to investigate whether platelet inhibition alone has a positive effect on the development of transplant arteriosclerosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1097-685X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
131
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1161-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16678605-Animals,
pubmed-meshheading:16678605-Aorta,
pubmed-meshheading:16678605-Arteriosclerosis,
pubmed-meshheading:16678605-Disease Models, Animal,
pubmed-meshheading:16678605-Graft Rejection,
pubmed-meshheading:16678605-Mice,
pubmed-meshheading:16678605-Mice, Inbred C57BL,
pubmed-meshheading:16678605-Mice, Inbred CBA,
pubmed-meshheading:16678605-Platelet Aggregation Inhibitors,
pubmed-meshheading:16678605-Ticlopidine,
pubmed-meshheading:16678605-Transplantation, Homologous
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Clopidogrel reduces the development of transplant arteriosclerosis.
|
|
pubmed:affiliation |
Department of Cardiac Surgery, Institute for Clinical Immunology, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
